Effectiveness of interventions to prevent or treat impaired fetal growth

Obstetrical and Gynecological Survey

Volumn 52, Issue 2, 1997, Pages 139-149

  Gülmezoglu, Metin ^a   De Onis, Mercedes ^b   Villar, José ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIMALARIAL AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; ERYTHROMYCIN; FOLIC ACID; MAGNESIUM; MAGNESIUM SULFATE; METHYLDOPA; TETRACYCLINE; ZINC;

ADULT; ANEMIA; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FETUS; FETUS GROWTH; HUMAN; HYPERTENSION; INFECTION; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MALARIA; MATERNAL DISEASE; META ANALYSIS; NUTRITIONAL DEFICIENCY; PREECLAMPSIA; PRENATAL CARE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SMOKING CESSATION; TREATMENT OUTCOME;

FETAL GROWTH RETARDATION; HUMANS; PRENATAL CARE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; RISK FACTORS; TREATMENT OUTCOME;

EID: 0343990751     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-199702000-00023     Document Type: Review

References (59)

1. Balcazar H, Haas JD. Retarded fetal growth patterns and early neonatal mortality in a Mexico city population. Bull Pan Am Health Organ 1991;25:55-63.
2. Kramer MS. Birth weight and infant mortality: Perceptions and pitfalls. Paediatr Perinat Epidemiol 1990;4:381-390.
3. Villar J, de Onis M, Kestler E et al. The differential morbidity of the intrauterine growth retardation syndrome. Am J Obstet Gynecol 1990;163:151-157.
4. Wilcox AJ, Russell IT. Birth weight and perinatal mortality: II. On weight-specific mortality. Int J Epidemiol 1983;12:319-325.
5. Williams RL, Creasy RK, Cunningham GC et al. Fetal growth and perinatal viability in California. Obstet Gynecol 1982;59: 624-632.
6. Øyen N, Skjaerven R, Little R et al. Fetal growth retardation in Sudden Infant Death Syndrome (SIDS) babies and their siblings. Am J Epidemiol 1995;142:84-90.
7. McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985;312: 82-90.
8. Paz I, Gale R, Laor A et al. The cognitive outcome of full-term small-for-gestational-age infants at late adolescence. Obstet Gynecol 1995;85:452-456.
9. Low J, Handley-Derry M, Burke S et al. Association of intrauterine fetal growth retardation and learning deficits at age 9 to 11 years. Am J Obstet Gynecol 1992;167:1499-1505.
10. Mervis CA, Decoufle P, Murphy CC et al. Low birth weight and the risk for mental retardation later in childhood. Paediatr Perinat Epidemiol 1995;9:455-468.
11. Parkinson CE, Wallis S, Harvey DR. School achievement and behaviour of children who are small-for-dates at birth. Dev Med Child Neurol 1981;23:41-50.
12. Taylor DJ, Howie PW. Fetal growth achievement and neurodevelopmental disability. Br J Obstet Gynaecol 1989;96:789-794.
13. Villar J, Smeriglio V, Martorell R et al. Heterogenous growth and mental development of intrauterine growth-retarded infants during the first 3 years of life. Pediatrics 1984;74:783-791.
14. Osmond C, Barker DJ, Winter PD et al. Early growth and death from cardiovascular disease in women. Br Med J 1993;307: 1519-1524.
15. Williams S, George I, Silva P. Intrauterine growth retardation and blood pressure at age 7 and 18. J Clin Epidemiol 1992; 45:1257-1263.
16. Barker DJP. The intrauterine origins of cardiovascular and obstructive lung disease in adult life: The Mark Daniels Lecture, 1990. J R Coll Physicians Lond 1991;25:129-133.
17. Hales CN, Barker DJ, Clark PM et al. Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J 1991; 303:1019-1022.
18. Barker DJ, Martyn CN, Osmond C et al. Growth in utero and serum cholesterol concentrations in adult life. Br Med J 1993; 307:1524-1527.
19. Hinchliffe SA, Lynch MR, Sargent PH et al. The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 1992;99:296-301.
20. Nieto-Diaz A, Villar J, Matorras-Weinig R et al. Intrauterine growth retardation at term: Association between anthropometric and endocrine parameters. Acta Obstet Gynecol Scand 1996;75:127-131.
21. Physical Status: The use and interpretation of anthropometry. Report of a WHO Expert Committee. Technical Report Series No. 854. Geneva: World Health Organization, 1995.
22. Lindhard A, Nielsen PV, Mouritsen LA et al. The implications of introducing the symphyseal-fundal height measurement. A prospective randomized controlled trial. Br J Obstet Gynaecol 1990;97:675-680.
23. Howarth GR, Pattinson RC. Inappropriate antenatal care. S Afr Med J 1993;83:798.
24. Ewignon B, Crane J, Frigoletto F et al. Effect of prenatal ultrasound screening on perinatal outcome. N Engl J Med 1993;329:821-827.
25. Wilcox AJ. Intrauterine growth retardation: Beyond birth weight criteria. Early Hum Dev 1983;8:189-193.
26. de Onis M, Habicht JP. Anthropometric reference data for international use: Recommendations from a World Health Organization Expert Committee. Am J Clin Nutr 1996;64:650-658.
27. Chalmers I. Evaluating the effects of care during pregnancy and childbirth. In: Chalmers I, Enkin M, Keirse MJNC, eds. Effective Care in Pregnancy and Childbirth. Oxford: Oxford University Press, 1989, pp 3-65.
28. Keirse MJNC, Renfrew MJ, Neilson JP et al., eds. Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995. Available from BMJ Publishing Group, London.
29. Ceesay SM, Prentice AM, Cole TJ et al. Maternal supplementation during pregnancy in a primary health care setting in rural Gambia: Effect on birth outcome. Proceedings of the Nutrition Society 1994, Summer Symposium, Southampton, England.
30. Rush D, Stein Z, Susser M. Diet in pregnancy: A randomized controlled trial of nutritional supplements. Birth Defects 1980; 16:1-187.
31. ECPPA Collaborative Group. Randomized trial of low-dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. Br J Obstet Gynaecol 1996;103: 39-47.
32. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. Br Med J 1990;301:587-589.
33. Rubin PC, Butters L, Clark DM et al. Placebo-controlled trial of atenolol in the treatment of pregnancy associated hypertension. Lancet 1983;1:431-434.
34. Oxman AD, Clarke MJ, Stewart LA. Meta-analyses using individual patient data are needed. J Am Med Assoc 1995;274: 845-846.
35. Jeng GT, Scott JR, Burmeister LF. A comparison of meta-analytic results using literature vs. individual patient data: Paternal cell immunization for recurrent miscarriage. J Am Med Assoc 1995;274:830-836.
36. Villar J, Carroli G, Belizan JM. Predictive ability of meta-analyses of randomized controlled trials. Lancet 1995;345: 772-776.
37. de Onis M, Blössner M, Villar J. Levels and patterns of intra-uterine growth retardation in developing countries. Eur J Clin Nutr 1997 (in press).
38. Villar J, Farnot U, Barros F et al. A randomized trial of psychosocial support during high-risk pregnancies. N Engl J Med 1992;327:1266-1271.
39. Langer A, Farnot U, Garcia C et al. The Latin America trial of psychosocial support during pregnancy: Effect on mother's well being and satisfaction. Soc Sci Med 1996;42:1589-1597.
40. Belizan JM, Barros F, Langer A et al. Impact of health education during pregnancy on behavior and utilization of health resources. Am J Obstet Gynecol 1995;173:894-899.
41. Cliver SP, Goldenberg RL, Cutter GR et al. The effect of cigarette smoking on neonatal anthropometric measurements. Obstet Gynecol 1995;85:625-630.
42. Kendrick JS, Zahniser SC, Miller N et al. Integrating smoking cessation into routine public prenatal care: The smoking cessation in pregnancy project. Am J Public Health 1995;85:217-222.
43. Garner P, Kramer MS, Chalmers I. Might efforts to increase birth weight in undernourished women do more harm than good? Lancet 1992;340:1021-1023.
44. Villar J, Rivera J. Nutritional supplementation during two consecutive pregnancies and the interim lactation period: Effect on birth weight. Pediatrics 1988;81:51-57.
45. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birth weight preterm infants? Pediatrics 1995;95:263-269.
46. Goldenberg RL, Tamura T, Neggers Y et al. The effect of zinc supplementation on pregnancy outcome. J Am Med Assoc 1995;274:463-468.
47. Jønsson B, Hauge B, Falmer Larsen M, et al. Zinc supplementation during pregnancy: A double blind randomized controlled trial. Acta Obstet Gynecol Scand 1996;75:725-729.
48. Carroli G, Duley L, Belizan JM et al. Calcium supplementation during pregnancy: A systematic review of randomized controlled trials. Br J Obstet Gynaecol 1994;101:753-758.
49. Bucher HC, Guyatt GH, Cook RJ et al. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: A meta-analysis of randomized controlled trials. J Am Med Assoc 1996;275:1113-1117.
50. CLASP Trial, Collaborative low dose Aspirin Study in Pregnancy Collaborative Group. MRC Collaborative low-dose Aspirin Study in Pregnancy (CLASP). Lancet 1994;343:619-629.
51. Ylikorkala O. Aspirin for the prevention of pre-eclampsia: Where do we stand now? Acta Obstet Gynecol Scand 1995; 74:407-409.
52. Sibai BM, Caritis SN, Thom E et al. Prevention of preeclampsia with low-dose aspirine in healthy, nulliparous pregnant women. N Engl J Med 1993;329:1213-1218.
53. McCaw-Binns A, the Jamaica Low-Dose Aspirin Study Group. Low dose aspirin in pregnancy - Are there any benefits? In: Proceedings 10th World Congress International Society for the Study of Hypertension in Pregnancy. Seattle, Washington, August 1996.
54. Crowther C. Commentary: Bedrest for women with pregnancy problems: Evidence for efficacy is lacking. Birth 1995;22:13-14.
55. Nicolaides KH, Bradley RJ, Soothill PW. Maternal oxygen therapy for intrauterine growth retardation. Lancet 1987;1: 942.
56. Tervila L, Vartiainen E, Kivalo I et al. The effect of oxygen ventilation and a vasodilator on uterine perfusion, fetal oxygen, and acid-base balance. II. A study in abnormal gravidae. Acta Obstet Gynecol Scand 1973;52:309-315.
57. Garner P, Brabin B. A review of randomized controlled trials of routine antimalarial drug prophylaxis during pregnancy in endemic malarious areas. Bull WHO 1994;72:89-99.
58. Taha TE, Gray R, Mohamedani A. Malaria and low birth weight in Central Sudan. Am J Epidemiol 1993;138:318-325.
59. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345:1455-1463.